623 articles
Brian Johnson's tirzepatide experiment sparked interest in microdosing GLP-1s for anti-aging, but evidence remains hypothetical with real risks.
Dr. Brad Stanfield reveals how common medications become dangerous with age and shares his deprescribing protocol.
Large clinical trial shows artificial sweeteners may help maintain weight loss and boost beneficial gut bacteria production.
New clinical trials show GLP-1 medications like Ozempic can reverse fatty liver disease in up to 62% of patients within 72 weeks.
New analysis claims dangerous lead levels in protein powders, but the safety thresholds used may be unnecessarily strict.
Dr. Stanfield reveals why longevity investments crash and burn, plus four medication classes showing real promise for healthspan extension.
UK Biobank study reveals vigorous activity has 4-9x greater health benefits than moderate exercise, challenging standard recommendations.
New research reveals how cholesterol-lowering medications dramatically reduce dementia risk when used long-term.
New research suggests falling testosterone levels may be due to changed testing methods, not actual biological decline.
A large study suggests melatonin increases heart failure risk, but critical methodology problems may invalidate the alarming findings.
New research reveals why normal BMI doesn't guarantee heart health and what critical metric doctors often forget to check.
Dr. Stanfield exposes the $3 billion IV therapy industry's lack of evidence and hidden dangers for longevity seekers.
